US Patent Issued to Tavotek Biotechnology (Jiangsu) on Dec. 2 for "Agents that interfere with IL-1BETA receptor signalling" (New Jersey, Pennsylvania Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,486,321, issued on Dec. 2, was assigned to Tavotek Biotechnology (Jiangsu) Co. Ltd (Suzhou, China).

"Agents that interfere with IL-1BETA receptor signalling" was invented by Di Zhang (Hillsborough, N.J.), Susan Tam (Garnet Valley, Pa.), Minseon Cho (Breinigsville, Pa.), Lihua Shi (Wynnewood, Pa.) and Man-Cheong Fung (Ringoes, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to antibodies that specifically bind and neutralize interleukin-1Beta (IL-1Beta), and to the use of such antibodies for the therapeutic treatment of IL-1Beta-mediated diseases and disorders."

The patent was filed on July 9, 2020, under Application No...